Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Phase II clinical trial on Gensia's second-generation adenosine-regulating agent commence

May 31, 1996

Gene transfer as treatment for myocardial ischemia

May 31, 1996

Valsartan approved in Germany

May 31, 1996

Endothelin antagonists revealed by Fujisawa

May 31, 1996

FDA to discuss ProAmatine application

May 24, 1996

Na+/K+-ATPase inhibitors disclosed by Sigma-Tau

May 24, 1996

Medco, Fujisawa to codevelop and comarket adenosine for CABG and AMI

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Update on fenoldopam regulatory submission

May 24, 1996

Progress on endothelin antagonists at Texas Biotechnology

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...